A detailed history of Sivia Capital Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Sivia Capital Partners, LLC holds 5,904 shares of NVS stock, worth $573,160. This represents 0.4% of its overall portfolio holdings.

Number of Shares
5,904
Previous 5,572 5.96%
Holding current value
$573,160
Previous $593 Million 14.48%
% of portfolio
0.4%
Previous 0.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$106.13 - $120.89 $35,235 - $40,135
332 Added 5.96%
5,904 $679 Million
Q2 2024

Aug 05, 2024

BUY
$92.57 - $107.37 $21,013 - $24,372
227 Added 4.25%
5,572 $593 Million
Q1 2024

Apr 18, 2024

BUY
$95.27 - $108.47 $5,335 - $6,074
56 Added 1.06%
5,345 $517 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $488,016 - $537,045
5,289 New
5,289 $534 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Sivia Capital Partners, LLC Portfolio

Follow Sivia Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivia Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivia Capital Partners, LLC with notifications on news.